Hui-Ming Lin

13PUBLICATIONS

60CO-AUTHORS

Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer diagnosis

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (13)

Sort by Publication Date:

|Jun 26, 2026

AI-Based Pathology classifier Predicts Sensitivity to Enzalutamide in Metastatic Hormone-Sensitive Prostate Cancer: A Biomarker Analysis of the ENZAMET Trial.

|Mar 06, 2026

A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.

Barak Talmor, Stefano Marastoni, Brandon Lau

|Jul 29, 2024

Circulating Lipid Profiles Associated With Resistance to Androgen Deprivation Therapy in Localized Prostate Cancer.

Hui-Ming Lin, Xiaoyu Yang, Margaret M Centenera

|May 01, 2024

Plasma Lipidomic Profiling Identifies Elevated Triglycerides as Potential Risk Factor in Chemotherapy-Induced Peripheral Neuropathy.

Nicole Yeung, Tiffany Li, Hui-Ming Lin

|Mar 28, 2024

Clinical validation of circulating GDF15/MIC-1 as a marker of response to docetaxel and survival in men with metastatic castration-resistant prostate cancer.

Kate L Mahon, Sarah Im Sutherland, Hui Ming Lin

|Jul 25, 2023

Multi-Omic Integration of Blood-Based Tumor-Associated Genomic and Lipidomic Profiles Using Machine Learning Models in Metastatic Prostate Cancer.

Shikai Fang, Shandian Zhe, Hui-Ming Lin

Pageof 3

Frequent Collaborators

Peter J Meikle

Lisa G Horvath

Anthony M Joshua

Lisa M Butler

Blossom Mak

Arun Azad

Andrew J Hoy

James G Kench

Kevin Huynh

Edmond M Kwan

Frequent Collaborators

Peter J Meikle

Lisa G Horvath

Anthony M Joshua

Lisa M Butler